Production problems

Approval of an alternative angina treatment will not resolve potential shortages resulting from issues with an existing drug   The TGA advised recently that it had approved an alternative product to glyceryl trinitrate  (GTN) tablets, which are sold in Australia under the brand names Anginine and Lycinate, for treating acute angina pectoris (chest or heart